奧拓電子(002587.SZ):2022年擬向銀行申請不超10億元的綜合授信額度
格隆匯3月31日丨奧拓電子(002587.SZ)公佈,公司於2022年3月30日召開的第五屆董事會第二次會議審議通過了《關於公司向銀行申請人民幣綜合授信額度的議案》,為滿足公司經營管理及發展的需要,拓寬融資渠道,公司(含納入公司合併報表範圍的下屬子公司)2022年擬向相關銀行申請不超過10億元的綜合授信額度,授信期限一年。綜合授信額度的業務範圍包括但不限於銀行承兑匯票、流動資金貸款等,具體金額及業務品種以銀行批覆為準。以上授信額度不等於公司的實際融資金額,實際融資金額應在授信額度內以銀行與公司實際發生的融資金額為準。授信期限內,授信額度可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.